LRN vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 17, 2026

LRN

35.1
AI Score
VS
UTI Wins

UTI

43.7
AI Score

Investment Advisor Scores

LRN

35score
Recommendation
AVOID NEW MONEY

UTI

44score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric LRN UTI Winner
Forward P/E 8.5616 27.248 LRN
PEG Ratio 0.4282 1.8142 LRN
Revenue Growth -2.7% 7.2% UTI
Earnings Growth 69.6% -78.9% LRN
Tradestie Score 35.1/100 43.7/100 UTI
Profit Margin 13.4% 3.9% LRN
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD UTI

Relative Price Performance (Last 90 Days)

LRN 1M: -0.2% · 3M: -9.8% UTI 1M: +3.9% · 3M: -43.9%

Current Technical Phase

LRN

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.2%), weak momentum, RSI 44

RSI (14): 43.7 · Price: $78.41

UTI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 53.5 · Price: $21.21

Fundamentals Snapshot

Metric LRN UTI
Market Cap — —
Forward P/E 8.8 28.3
Trailing P/E 11.1 33.8
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.4% 0.6%
Operating Margin 0.2% 0.0%
EPS 7.14 0.61
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, UTI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.